Avai Bio (AVAI) Shares Outstanding (2020 - 2026)

Avai Bio has disclosed Shares Outstanding (Entity) across 7 years of filings, most recently posting $153.9 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 11.93% year-over-year to $153.9 million; the TTM figure through Jun 2026 stood at $153.9 million (up 11.93% YoY), while the FY2026 annual figure was $153.2 million, up 11.54% from the prior year.
• Shares Outstanding (Entity) came in at $153.9 million for Q2 2026 at Avai Bio, roughly flat from $153.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $153.9 million in Q2 2026 to a low of $26.3 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $93.8 million, with a median of $101.8 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) changed 0.0% in 2022 and surged 222.22% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $26.3 million in 2022, then surged by 222.22% to $84.8 million in 2023, then surged by 61.72% to $137.1 million in 2024, then climbed by 0.66% to $138.0 million in 2025, then grew by 11.51% to $153.9 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $153.9 million in Q2 2026, $153.2 million in Q1 2026, and $138.0 million in Q4 2025.